Capital Fund Management S.A. Has $822,000 Position in Perrigo Company plc (NYSE:PRGO)

Capital Fund Management S.A. lessened its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 48.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,990 shares of the company's stock after selling 29,924 shares during the quarter. Capital Fund Management S.A.'s holdings in Perrigo were worth $822,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Franklin Resources Inc. purchased a new position in shares of Perrigo in the 3rd quarter worth about $3,717,000. Barclays PLC grew its stake in Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company's stock worth $3,160,000 after purchasing an additional 37,268 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Perrigo by 65.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock valued at $14,190,000 after acquiring an additional 213,221 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Perrigo in the 3rd quarter worth about $909,000. Finally, Access Investment Management LLC acquired a new stake in shares of Perrigo during the 4th quarter worth approximately $7,989,000. Institutional investors and hedge funds own 95.91% of the company's stock.

Perrigo Trading Up 0.8 %

PRGO traded up $0.21 during trading on Friday, reaching $25.35. The company had a trading volume of 848,405 shares, compared to its average volume of 1,526,585. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $33.46. The firm's 50-day simple moving average is $26.49 and its 200 day simple moving average is $26.05. The company has a market cap of $3.46 billion, a price-to-earnings ratio of -21.66 and a beta of 0.49. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.01. The firm had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. Equities research analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Investors of record on Friday, March 7th were given a $0.29 dividend. This is a boost from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a yield of 4.58%. The ex-dividend date was Friday, March 7th. Perrigo's dividend payout ratio (DPR) is -92.80%.

Analyst Ratings Changes

Several research analysts have commented on the stock. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday, January 14th. StockNews.com lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Finally, Piper Sandler cut Perrigo from an "overweight" rating to a "neutral" rating and lowered their price target for the company from $34.00 to $27.00 in a research report on Monday, January 6th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $33.00.

Insider Buying and Selling at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the sale, the executive vice president now owns 33,666 shares of the company's stock, valued at $923,795.04. This represents a 18.81 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.70% of the company's stock.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.